Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration.
Proyecto:
Instituto de Salud Carlos III PID2020-115683GA-I00
,
Agencia Estatal de Investigación PID2020-118127RB-I00
,
Agencia Estatal de Investigación PGC2018-102192-B-I00
,
Agència de Gestió d'Ajuts Universitaris i de Recerca PID2019-106285RB
,
Agencia Estatal de Investigación SAF2017-82771-R
,
Ministerio de Educación FPU15/01131
,
Cultura y Deporte 2019LLAV00017
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1707
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-106
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 679001